CHS-114-102: A PHASE 1B, MULTICENTER, OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF CHS-114 IN COMBINATION WITH TORIPALIMAB WITH OR WITHOUT OTHER TREATMENTS IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS
The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in participants with advanced or metastatic solid tumors.
Why this Research Matters
The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in participants with advanced or metastatic solid tumors.
Who can Participate
Detailed eligibility criteria is available on ClinicalTrials.gov. These requirements will be discussed with your doctor and/or study representative. ClinicalTrials.gov to learn more about this study. https://clinicaltrials.gov/study/NCT06657144?term=NCT06657144&rank=1
Study ID
Protocol Number: 25-1556
More information available at ClinicalTrials.gov: NCT06657144
Meet the Team
Principal Investigator